Pain and Effusion and Quadriceps Activation and Strength
Pain and Effusion and Quadriceps Activation and Strength
Pain and Effusion and Quadriceps Activation and Strength
doi: 10.4085/1062-6050-48.2.10
Ó by the National Athletic Trainers’ Association, Inc original research
www.natajournals.org
Context: Quadriceps dysfunction is a common consequence Results: Quadriceps strength and activation were highest
of knee joint injury and disease, yet its causes remain elusive. under the normal knee condition and differed from the 3
Objective: To determine the effects of pain on quadriceps experimental knee conditions (P , .05). No differences were
strength and activation and to learn if simultaneous pain and knee noted among the 3 experimental knee conditions for either
joint effusion affect the magnitude of quadriceps dysfunction. variable (P . .05).
Design: Crossover study.
Setting: University research laboratory. Conclusions: Both pain and effusion led to quadriceps
Patients or Other Participants: Fourteen (8 men, 6 dysfunction, but the interaction of the 2 stimuli did not increase
women; age ¼ 23.6 6 4.8 years, height ¼ 170.3 6 9.16 cm, the magnitude of the strength or activation deficits. Therefore,
mass ¼ 72.9 6 11.84 kg) healthy volunteers. pain and effusion can be considered equally potent in eliciting
Intervention(s): All participants were tested under 4 ran- quadriceps inhibition. Given that pain and effusion accompany
domized conditions: normal knee, effused knee, painful knee, numerous knee conditions, the prevalence of quadriceps
and effused and painful knee. dysfunction is likely high.
Main Outcome Measure(s): Quadriceps strength (Nm/kg)
and activation (central activation ratio) were assessed after each Key Words: arthrogenic muscle inhibition, central activation
condition was induced. failure, voluntary activation, muscles
Key Points
Knee pain and effusion resulted in arthrogenic muscle inhibition and weakness of the quadriceps.
The simultaneous presence of pain and effusion did not increase the magnitude of quadriceps dysfunction.
To reduce arthrogenic muscle inhibition and improve muscle strength, clinicians should employ interventions that
target removing both pain and effusion.
they performed the previously described MVICs for knee effusion always preceded the injection for pain because the
extension. The central activation ratio (CAR) was calcu- pain resolved more quickly than the effusion.
lated for each repetition using the following equation:
Pain Ratings
MVIC torque
CAR ¼ ; After each experimental condition, participants were
superimposed burst torque
instructed to complete a short-form McGill Pain Question-
where MVIC torque was the peak torque recorded before naire. The visual analog scale (10-cm line) included on this
the delivery of the electrical stimulus, and superimposed- form was used to estimate the overall intensity of pain
burst torque was the maximal torque value elicited via the participants experienced in their knees due to the injection
electrical stimulus. A CAR equal to 1.0 represents maximal or injections. The pain rating was taken approximately 1
voluntary activation, but a CAR equal to 0.95 represents minute after the injection, which was before the completion
complete or normal activation.25 The average CAR over the of the quadriceps strength and activation assessment.
3 repetitions was used to quantify quadriceps AMI.
Statistical Analysis
Experimental Knee-Effusion Procedures
We used 2 separate 1 3 4 repeated-measures analyses of
To induce the experimental knee-joint effusion, the area variance to compare quadriceps strength and activation
superolateral to the patella of the dominant lower extremity across the 4 conditions. Similarly, we used a repeated-
was cleaned with alcohol and povidone-iodine. All measures analysis of variance to compare the pain ratings
participants’ lower extremities were placed in extension across the 4 conditions. Bonferroni multiple-comparisons
while they lay supine in the dynamometer chair, which was procedures were employed post hoc. The a level was set at
fully reclined. We used a sterile syringe with a 25-gauge, equal to or less than .05 for all tests. Effect sizes (95%
1.5-inch needle to inject 3 mL of 1% lidocaine subcutane- confidence intervals [CIs]) were quantified for each
ously to anesthetize the skin. After the lidocaine was condition between the normal knee condition and the
released from the syringe, the needle was guided into the experimental knee condition (effused, painful, or effused
knee joint capsule, a 60-mL syringe was attached, and 60 and painful) using the Cohen d ([group mean normal
mL of sterile saline was injected into the subcapsular group mean at experimental condition]/the pooled standard
synovial cavity.7,26 After the injection, we performed a deviation). To establish between-sessions reliability of our
sweep test to confirm the saline was in the knee joint dependent measurements, intraclass correlation coefficients
capsule. All injections were performed by the same (ICC) (2,1) 6 standard error of the mean were calculated
investigator (B.D.), a certified physician assistant. using the torque and CAR data recorded at each session
before the delivery of any injections.
Experimental Knee-Pain Procedures
To induce experimental knee pain, participants were RESULTS
positioned as described for the knee-effusion injection. An Effect sizes and their 95% CIs for quadriceps strength and
area inferior and medial to the patella was cleaned with activation are presented in Table 1. The between-sessions
alcohol and povidone-iodine. We used a sterile syringe with reliability for our measurements was high (MVIC ¼ 0.924 6
a 25-gauge, 1.5-inch needle to inject 0.3 mL of 5% 0.192; CAR ¼ 0.91 6 0.027), suggesting that our comparison
hypertonic saline into the medial infrapatellar fat pad. After across days can be considered with confidence.
being injected with the hypertonic saline, participants were
instructed verbally to rate their pain on a scale of 0 (no
Strength and Activation
pain) to 10 (worst pain). Participants who rated their pain
as 5 or more did not receive a second injection of We noted differences between conditions for both
hypertonic saline. Participants who rated their pain as less quadriceps strength (F3,39 ¼ 7.56, P , .001) and activation
than 5 on the scale were injected with another 0.3-mL bolus (F3,39 ¼ 6.21, P ¼ .001; Figures 1 and 2). The quadriceps
of 5% hypertonic saline. Nine of 14 volunteers required the strength recorded during the normal knee condition (2.49 6
second injection of hypertonic saline. The described 0.70 Nm/kg) differed from the other 3 knee conditions
procedures were similar to those used in previous (effused: 2.16 6 0.69 Nm/kg, P ¼ .04; painful: 2.15 6
investigations.19,27,28 Participants were not informed in 0.71, P ¼ .01; effused and painful: 1.96 6 0.77, P ¼ .009)
advance of the criterion used to determine the need for and was greatest under the normal knee condition.
administration of a second injection. Similarly, the CAR was highest under the normal knee
For the effused and painful condition, we followed the condition (0.88 6 0.09) and differed from the 3
procedures described for both conditions. The injection for experimental knee conditions (effused: 0.81 6 0.11, P ¼
.01; painful: 0.83 6 0.11, P ¼ .03; effused and painful: 0.79 quadriceps muscle strength and activation. Both the effused
6 0.11, P ¼ .02). We did not note differences among the 3 knee and painful knee groups demonstrated quadriceps
experimental knee conditions for either quadriceps strength muscle dysfunction, but the amounts of quadriceps
or activation (P . .05). activation and strength deficits were not magnified when
these 2 stimuli were present simultaneously.
Pain Reports are conflicting about whether the presence of
pain results in quadriceps dysfunction. Shakespeare29 noted
We found differences between conditions for intensity of
that quadriceps inhibition can occur in the absence of
pain (F3,39 ¼ 35.16, P , .001; Table 2). The intensity of
perceived pain in patients after meniscectomy, whereas
pain was lower under the normal knee condition than under
Arvidsson et al30 found that reducing pain via epidural
the 3 experimental knee conditions (effused: P ¼ .02;
injections of lidocaine can increase quadriceps electromyo-
painful: P , .001; effused and painful: P , .001). The
graphic activity in patients after ACL reconstruction.
intensity of pain was greater during the painful condition
than the effused condition (P ¼ .005) but not the effused Similarly, pain has been shown to be both related31 and
and painful condition (P ¼ .98). In addition, the intensity of unrelated32 to quadriceps strength and activation in patients
pain was lower during the effused condition than the undergoing total knee arthroplasty. Our study was different
effused and painful condition (P ¼ .001). from those earlier reports because we examined a cause-
and-effect relationship between pain and quadriceps
activation and strength. We showed that moderate amounts
DISCUSSION of pain created a small magnitude of quadriceps AMI (5.7%
We used experimental knee pain and effusion models to change from the normal knee condition) and also resulted in
examine the effects that pain and effusion may have on a decline in quadriceps strength (13.7% change from the
Figure 2. Quadriceps central activation ratio (CAR) for each knee conditions. a Indicates difference from the other 3 knee conditions (P ,
.05).
Address correspondence to Riann M. Palmieri-Smith, PhD, ATC, School of Kinesiology, University of Michigan, 4745G CCRB, 401
Washtenaw Avenue, Ann Arbor, MI 48109-2214. Address e-mail to [email protected].